Sign in with Google. Opens in new tab
bearish
Celltrion (068270): Time Is Not Right for Short Sellers Yet
464 Views13 Aug 2018 23:09
First, let me tell you this. I'm also a Celltrion basher. I don't like their accounting practices and dual company structure. Not only that,...
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 5-minute read)
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »Top Unpaywalled Insights
More »- Curator's Cut: Building Materials Moves, Benchmarking Gold Miners & Semaglutide in India and Japan
- [IO Technicals 2025/25] Bearish Momentum Strengthens
- VEON (VEON US): Launches Third Phase of Share Buyback Program After Share Pullback
- Valuations, Visas & Venture Pullback: An Equity + M&A Overview of the Education Sector in Q1 2025
- Overview #27 – The Big Beautiful Tragi-Comedy Continues
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Celltrion Healthcare Placement: Two Mitigating Factors, Short Healthcare But Long Celltrion18 Sep 2018
- Celltrion Healthcare Placement: Weigh Down from FDA Uncertainty and Placement Overhang18 Sep 2018
- Another Negative Sign for Celltrion: Remsima Retail Price Is Falling Too Fast Too Much30 Aug 2018
- Celltrion: Manufacturing Risks Remain07 Aug 2018
- Sell Celltrion Inc (068270 KS): Story Unravelling26 Jul 2018
- Celltrion's FDA CRL Issue Summary08 Apr 2018
x